Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study from the Société Francophone De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)

Blood (2023) 142 (Supplement 1): 2235.

https://doi.org/10.1182/blood-2023-184383

Published: 2023

Journal Articles

Late Effects of Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma. Swiss Cohort Analysis 1997-2021

Ekaterina Rebmann, Alexander von Werdt, Arnaud Künzi, Nathan Wolfensberger, Helen Baldomero, Michael Medinger, Jakob R. Passweg, Gayathri Nair, Stavroula Masouridi-Levrat, Yves Chalandon, Alicia Rovó

Blood (2023) 142 (Supplement 1): 7038.

https://doi.org/10.1182/blood-2023-190579

Published: 2023

Journal Articles

T Cell Receptor Repertoire Profiling Reveals Breadth of Cellular Responses Against Sars-Cov-2 after Natural Infection and Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Anne-Claire Mamez, Amandine Pradier, Caroline Stephan, Federica Giannotti, Stavroula Masouridi-Levrat, Sarah Morin, Dionysios Neofytos, Diem-Lan Vu, Astrid Melotti, Isabelle Arm-Vernez, Christiane S. Eberhardt, Jerome Tamburini, Laurent Kaiser, Yves Chalandon, Federico Simonetta

Blood (2022) 140 (Supplement 1): 10509–10511.

https://doi.org/10.1182/blood-2022-156983

Published: 2022

Journal Articles

Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

Blood (2022) 140 (Supplement 1): 2126–2129.

https://doi.org/10.1182/blood-2022-157684

Published: 2022

Journal Articles

Expansion of Phenotypically Senescent CD57+ CD8 T Cells Is Associated with Impaired Immunocompetence after Allogeneic Hematopoietic Stem Cell Transplantation

Sarah Morin, Amandine Pradier, Federica Giannotti, Anne-Claire Mamez, Diem-Lan Vu-Cantero, Marta Fabra-Urdiola, Caroline Stephan, Chiara Bernardi, Astrid Melotti, Stavroula Masouridi-Levrat, Eddy Roosnek, Laurent Kaiser, Yves Chalandon, Federico Simonetta

Blood (2021) 138 (Supplement 1): 1807.

https://doi.org/10.1182/blood-2021-153133

Published: 2021

Journal Articles

The AML EBMT Cytogenetic Risk Score for Acute Myeloid Leukaemia (AML) Is Prognostic for Outcomes of Allogeneic Stem Cell (HSCT)

Yan Beauverd, MD, Sarah Morin, MD PhD, Mitja Nabergoj, Caroline Stephan, Carmen De Ramon Ortiz, MD, Anne-Claire Mamez, MD, Elif Mahne, MD, Anna Petropoulou, MD, Federica Giannotti, MD, Federico Simonetta, MDPhD, Christian Ayer, MD, Benjamin Bruno, MD, Laura Bounaix, MD, Maria Anastasiou, MD, Maria Mappoura, MD, Thien-An Tran, MD, Stavroula Masouridi-Levrat, MD, Yves Chalandon, MD

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-140010

Published: 2020

Journal Articles

Real-Life Experience of Sorafenib Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD AML Reveals High Rates of Toxicity-Related Treatment Interruption

Sarah Morin, MD PhD, Federica Giannotti, MD, Anne-Claire Mamez, MD, Stavroula Masouridi-Levrat, MD, Federico Simonetta, MDPhD, Yves Chalandon, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-138663

Published: 2020

Journal Articles

Impact of Different T Cell Depletion Protocols on Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-139208

Published: 2020

Journal Articles

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Federico Simonetta, MD PhD, Hélène Labussière-Wallet, MD, Maciej J Machaczka, MD, Flore Sicre de Fontbrune, MD, Michael Medinger, MD, Sylvain Chantepie, MD, Tony Marchand, MD, Stavroula Masouridi-Levrat, MD, Marie-Thérèse Rubio, MD PhD, Oumedaly Reman, MD, Nathalie Dhedin, MD, Loic Fouillard, MD, Olivier Lambotte, MD PhD, Lionel Galicier, MD, Paul Coppo, MD PhD, Jakob Passweg, MD, Ibrahim Yakoub-Agha, MD PhD, Regis Peffault De Latour, MD PhD, Yves Chalandon, MD

Blood (2016) 128 (22): 4617.

https://doi.org/10.1182/blood.V128.22.4617.4617

Published: 2016

Journal Articles

Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Yves Chalandon, MD, Federico Simonetta, MD PhD, Carole Dantin, MSc, Aikaterini Koutsi, MD, Anne-Claire Mamez, MD, Yan Beauverd, MD, Olga Tsopra, MD, Audrey Simon, MD, Stijn Bex, MD, Caroline Stephan, MD, Juan Felipe Rodriguez Morales, MD, Karolina Polchlopek, MD, Marc Ansari, MD, Yordanka Tirefort, MD, Eddy Roosnek, PhD, Stavroula Masouridi-Levrat, MD

Blood (2016) 128 (22): 2204.

https://doi.org/10.1182/blood.V128.22.2204.2204

Published: 2016

Journal Articles

T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Federico Simonetta, MD PhD, Stavroula Masouridi-Levrat, MD, Yan Beauverd, MD, Olga Tsopra, MD, Yordanka Tirefort, MD, Caroline Stephan, MD, Karolina Polchlopek, MD, Riccardo Favale, MD, Carole Dantin, MSc, Marc Ansari, MD, Eddy Roosnek, PhD, Yves Chalandon

Blood (2015) 126 (23): 3204.

https://doi.org/10.1182/blood.V126.23.3204.3204

Published: 2015

Journal Articles

Decreased Incidence of GvHD after Reduced Intensity Conditioning and a Fixed T-CELL Dose in Hematological Malingnancy Patients

Audrey Simon, Eddy Roosnek, Yordanka Tirefort, Yan Beauverd, Carole Dantin, Olga Tsopra, Jakob R. Passweg, MD, Stavroula Masouridi-Levrat, Yves Chalandon

Blood (2014) 124 (21): 5889.

https://doi.org/10.1182/blood.V124.21.5889.5889

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cells Transplantation for Non-Hodgkin’s Lymphoma. The Swiss Experience 1985-2014

Ekaterina Chigrinova, Sara Fertani, Helen Baldomero, Eddy Roosnek, Gayathri Nair, Johanna Schep, Stavroula Masouridi-Levrat, Urs Schanz, MD, Jakob Passweg, Yves Chalandon

Blood (2014) 124 (21): 1256.

https://doi.org/10.1182/blood.V124.21.1256.1256

Published: 2014

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study from the Société Francophone De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)

Late Effects of Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma. Swiss Cohort Analysis 1997-2021

T Cell Receptor Repertoire Profiling Reveals Breadth of Cellular Responses Against Sars-Cov-2 after Natural Infection and Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

Expansion of Phenotypically Senescent CD57+ CD8 T Cells Is Associated with Impaired Immunocompetence after Allogeneic Hematopoietic Stem Cell Transplantation

The AML EBMT Cytogenetic Risk Score for Acute Myeloid Leukaemia (AML) Is Prognostic for Outcomes of Allogeneic Stem Cell (HSCT)

Real-Life Experience of Sorafenib Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD AML Reveals High Rates of Toxicity-Related Treatment Interruption

Impact of Different T Cell Depletion Protocols on Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Decreased Incidence of GvHD after Reduced Intensity Conditioning and a Fixed T-CELL Dose in Hematological Malingnancy Patients

Allogeneic Hematopoietic Stem Cells Transplantation for Non-Hodgkin’s Lymphoma. The Swiss Experience 1985-2014

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only